BACKGROUND: Complementary/alternative medicine (CAM) is gaining increasing importance especially in the treatment of patients with breast carcinoma. The purpose of this analysis was to investigate the prevalence of CAM in patients with breast carcinoma, to statistically describe the preparations and therapies used, and to determine the reasons for their use, the source of information and the individual perception. PATIENTS AND METHODS: The statements of 203 patients with breast carcinoma who underwent radiotherapy were analyzed. The median age was 54 years (range 38-77 years). All patients underwent surgery as first therapy. 36 patients received a second-line radiotherapy because of metastases (27 patients) or local recurrence (9 patients). RESULTS: 159 patients (78%) stated to carry out an additional treatment. 31 out of the 36 patients with metastases or local recurrence used CAM. Vitamin preparations (67%), mistletoe therapy (59%), and mineral preparations (33%) were used most frequently. 70% of the patients used a combination of two or more preparations/therapies. The most cited reason for using CAM was the aim of increasing quality of life (28%) and improving the immune system (27%). 72% stated an improvement of their individual perception. The main source of information was the general practitioner or the gynecologist. CONCLUSION: The radiotherapist has to take these complementary/alternative therapies into consideration; their importance should be evaluated in further studies. Copyright 2003 S. Karger GmbH, Freiburg
BACKGROUND: Complementary/alternative medicine (CAM) is gaining increasing importance especially in the treatment of patients with breast carcinoma. The purpose of this analysis was to investigate the prevalence of CAM in patients with breast carcinoma, to statistically describe the preparations and therapies used, and to determine the reasons for their use, the source of information and the individual perception. PATIENTS AND METHODS: The statements of 203 patients with breast carcinoma who underwent radiotherapy were analyzed. The median age was 54 years (range 38-77 years). All patients underwent surgery as first therapy. 36 patients received a second-line radiotherapy because of metastases (27 patients) or local recurrence (9 patients). RESULTS: 159 patients (78%) stated to carry out an additional treatment. 31 out of the 36 patients with metastases or local recurrence used CAM. Vitamin preparations (67%), mistletoe therapy (59%), and mineral preparations (33%) were used most frequently. 70% of the patients used a combination of two or more preparations/therapies. The most cited reason for using CAM was the aim of increasing quality of life (28%) and improving the immune system (27%). 72% stated an improvement of their individual perception. The main source of information was the general practitioner or the gynecologist. CONCLUSION: The radiotherapist has to take these complementary/alternative therapies into consideration; their importance should be evaluated in further studies. Copyright 2003 S. Karger GmbH, Freiburg
Authors: Ralph Muecke; Magdalena Paul; Christina Conrad; Christoph Stoll; Karsten Muenstedt; Oliver Micke; Franz J Prott; Jens Buentzel; Jutta Huebner Journal: Integr Cancer Ther Date: 2015-07-26 Impact factor: 3.279
Authors: Magda Paul; B Davey; B Senf; C Stoll; K Münstedt; R Mücke; Oliver Micke; F J Prott; J Buentzel; Jutta Hübner Journal: J Cancer Res Clin Oncol Date: 2013-07-06 Impact factor: 4.553
Authors: Jutta Huebner; Karsten Muenstedt; Franz J Prott; Christoph Stoll; Oliver Micke; Jens Buentzel; Ralph Muecke; Bianca Senf Journal: Breast Care (Basel) Date: 2014-02 Impact factor: 2.860
Authors: Vinjar Fønnebø; Sameline Grimsgaard; Harald Walach; Cheryl Ritenbaugh; Arne Johan Norheim; Hugh MacPherson; George Lewith; Laila Launsø; Mary Koithan; Torkel Falkenberg; Heather Boon; Mikel Aickin Journal: BMC Med Res Methodol Date: 2007-02-11 Impact factor: 4.615
Authors: Evelyn Klein; Matthias W Beckmann; Werner Bader; Cosima Brucker; Gustav Dobos; Dorothea Fischer; Volker Hanf; Annette Hasenburg; Sebastian M Jud; Matthias Kalder; Marion Kiechle; Sherko Kümmel; Andreas Müller; Myrjam-Alice T Müller; Daniela Paepke; Andre-Robert Rotmann; Florian Schütz; Anton Scharl; Petra Voiss; Markus Wallwiener; Claudia Witt; Carolin C Hack Journal: Arch Gynecol Obstet Date: 2017-06-08 Impact factor: 2.344